Runda Medical released its 2026 interim report, with total operating revenue of 3.194 billion yuan and net profit attributable to the parent company of minus 87.867 million yuan, an increase of 32.7852 million yuan compared with the same period last year, narrowing the loss. Net cash inflow from operating activities was 273 million yuan, up 77.69 percent year-on-year, achieving growth for four consecutive years. The company's asset-liability ratio was 63.13 percent, and gross margin was 24.49 percent, up 3.55 percentage points from the same period last year. Diluted earnings per share were minus 0.15 yuan, and the number of shareholders was 56,200.
Shanghai Runda Med Tech CoNet loss of 87.867 million yuan, though narrowed, remains negative.
